Cerba Lancet Africa, a joint venture established in 2019 between Cerba HealthCare (France) and Lancet Laboratories (South Africa), is at the forefront of transforming Africa’s healthcare system from curative to preventive. With over 50 years of expertise in clinical pathology, their mission is to unlock the full potential of diagnostics across the continent.
The partnership began with clinical trials in South Africa and has since expanded to serve the entire African region. Both companies bring decades of experience, with Lancet Laboratories deeply rooted in sub-Saharan Africa and Cerba HealthCare providing specialty testing in West Africa and the Maghreb.
Driven by a shared vision of medical excellence, innovation, and patient-focused care, Cerba Lancet Africa offers first-class pathology services. During the COVID-19 pandemic, the collaboration between Cerba HealthCare in France and Lancet Laboratories played a key role in Africa’s response, providing valuable insights and protocols to aid in diagnosis and treatment.
Today, Cerba Lancet Africa continues to lead in diagnostics, offering accessible, world-class services across the continent.